ASCO: Eribulin results ‘a giant step for sarcoma’

CHICAGO – For the first time ever, a new drug has shown a survival advantage – albeit a small one – in metastatic soft tissue sarcomas, diseases that are almost without exception unresponsive to...

Field of Interest: Oncology
Type: News Item

VIDEO: Nivolumab puts brakes on advanced liver cancer

CHICAGO – Immune checkpoint inhibition with nivolumab every 2 weeks provides a better response than does standard treatment for advanced liver cancer, phase I/II results suggest. The overall...

Field of Interest: Oncology
Type: News Item

Thyroid surgery on the rise

There was a steady rise in the number of endocrine procedures being performed in the United States over the past decade, according to a new publication from the Endocrine Society. Thyroid disease...

Field of Interest: Pulmonology
Type: News Item

Severe acne erupts during transgender transition

Individuals undergoing a transition from female to male (trans men) may be prone to severe acne in response to the testosterone therapy associated with that process, according to data from case...

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness